Fanning James, Hojat Rod, Johnson Jil, Fenton Bradford
Summa Health System, Northeastern Ohio Universities College of Medicine, Akron, Ohio 44304, USA.
JSLS. 2010 Jan-Mar;14(1):80-2. doi: 10.4293/108680810X12674612014707.
We evaluated the feasibility of laparoscopic cytoreduction for primary advanced ovarian cancer.
All patients with presumed stage 3/4 primary ovarian cancer underwent attempted laparoscopic cytoreduction. All patients had CT evidence of omental metastasis and ascites. A 5-port (5-mm) transperitoneal approach was used. A bilateral salpingo-oophorectomy, supracervical hysterectomy, and omentectomy were performed with PlasmaKinetic (PK) cutting forceps. A laparoscopic 5-mm Argon-Beam Coagulator was used to coagulate tumor in the pelvis, abdominal peritoneum, intestinal mesentery, and diaphragm.
Nine of 11 cases (82%) were successfully debulked laparoscopically without conversion to laparotomy. Median operative time was 2.5 hours, and median blood loss was 275 mL. All tumors were debulked to <2 cm and 45% had no residual disease. Stages were 1-3B, 7-3C, and 1-4. Median length of stay was one day. Median VAS pain score was 4 (discomforting). Two of 11 patients (18%) had postoperative complications.
Laparoscopic cytoreduction was successful and resulted in minimal morbidity. Because of our small sample size, additional studies are needed.
我们评估了腹腔镜细胞减灭术治疗原发性晚期卵巢癌的可行性。
所有疑似3/4期原发性卵巢癌患者均尝试接受了腹腔镜细胞减灭术。所有患者均有CT证据显示存在大网膜转移和腹水。采用五孔(5毫米)经腹入路。使用等离子动力(PK)钳进行双侧输卵管卵巢切除术、次全子宫切除术和大网膜切除术。使用腹腔镜5毫米氩束凝固器对盆腔、腹腔腹膜、肠系膜和膈肌的肿瘤进行凝固。
11例患者中有9例(82%)成功通过腹腔镜实现肿瘤细胞减灭,未中转开腹。中位手术时间为2.5小时,中位失血量为275毫升。所有肿瘤均减灭至<2厘米,45%的患者无残留病灶。分期为1-3B、7-3C和1-4。中位住院时间为1天。中位视觉模拟评分(VAS)疼痛评分为4分(不适)。11例患者中有2例(18%)出现术后并发症。
腹腔镜细胞减灭术取得成功,且发病率极低。由于我们的样本量较小,因此需要进一步研究。